Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025

 Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 31 July 2025 – 7:00 AM CET Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025 Fagron, the leading global player in pharmaceutical compounding today publishes its first half results for the period ending 30 June 2025. Key Highlights Strong revenue performance with 10.9% reported revenue growth (14.4% at CER1) and 11.3% organic growth at...

Rotterdam, 31/07/2025 (informazione.news - comunicati stampa - salute e benessere)

 

Regulated information - inside information
Nazareth (Belgium)/Rotterdam (The Netherlands), 31 July 2025 – 7:00 AM CET

Fagron, the leading global player in pharmaceutical compounding today publishes its first half results for the period ending 30 June 2025.

                                                      

 

Constant Exchange Rate

 

Attachment